These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2155316)

  • 1. Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height.
    Balsan S; Tieder M
    J Pediatr; 1990 Mar; 116(3):365-71. PubMed ID: 2155316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final height of Japanese patients with X-linked hypophosphatemic rickets: effect of vitamin D and phosphate therapy.
    Miyamoto J; Koto S; Hasegawa Y
    Endocr J; 2000 Apr; 47(2):163-7. PubMed ID: 10943740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia.
    Cohanim M; DeLuca HF; Yendt ER
    Johns Hopkins Med J; 1972 Aug; 131(2):118-32. PubMed ID: 4340527
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G; Baroncelli GI; Bertelloni S; Perri G
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
    N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of treatment on growth and deformity in hypophosphatemic vitamin D-resistant rickets.
    Loeffler RD; Sherman FC
    Clin Orthop Relat Res; 1982; (162):4-10. PubMed ID: 6279346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets.
    Lewy JE; Cabana EC; Repetto HA; Canterbury JM; Reiss E
    J Pediatr; 1972 Aug; 81(2):294-300. PubMed ID: 4339535
    [No Abstract]   [Full Text] [Related]  

  • 8. [Growth hormone treatment of familial hypophosphatemic rickets].
    Saggese G; Baroncelli GI; Barsanti S
    Arch Pediatr; 1998; 5 Suppl 4():360S-363S. PubMed ID: 9853084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
    al-Aqeel A; Ozand P; Sobki S; Sewairi W; Marx S
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of growth with combined vitamin D-phosphate therapy of hypophosphatemic resistant rickets.
    McEnery PT; Silverman FN; West CD
    J Pediatr; 1972 May; 80(5):763-74. PubMed ID: 5018387
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE; Glorieux FH
    Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypophosphatemic rickets: a delineation of its subdivisions and pathogenesis.
    Walton J
    Clin Pediatr (Phila); 1976 Nov; 15(11):1007-12. PubMed ID: 184998
    [No Abstract]   [Full Text] [Related]  

  • 16. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.
    Balsan S; Garabedian M
    J Clin Invest; 1972 Apr; 51(4):749-59. PubMed ID: 4335443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.
    Glorieux FH; Scriver CR; Reade TM; Goldman H; Roseborough A
    N Engl J Med; 1972 Sep; 287(10):481-7. PubMed ID: 4340235
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypophosphatemic rickets: still misdiagnosed and inadequately treated.
    Greene WB; Kahler SG
    South Med J; 1985 Oct; 78(10):1179-84. PubMed ID: 2996152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of the main derivatives of vitmain D in 3 siblings with "pseudo-deficiency" rickets].
    Dommergues JP; Garabedian M; Gueris J; Le Deunff MJ; Creignou L; Courtecuisse V; Balsan S
    Arch Fr Pediatr; 1978 Dec; 35(10):1050-62. PubMed ID: 219799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth in X-linked hypophosphatemic rickets.
    Ariceta G; Langman CB
    Eur J Pediatr; 2007 Apr; 166(4):303-9. PubMed ID: 17171343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.